谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Eribulin Versus S1 As First- or Second-Line Chemotherapy to Assess Health-related Quality of Life and Overall Survival in HER2-negative Metastatic Breast Cancer (RESQ Study): a Non-Inferiority, Randomized Controlled Trial

Yuichiro Kikawa,Kosuke Kashiwabara,Naruto Taira,Tsuguo Iwatani,Kojiro Shimozuma,Shoichiro Ohtani,Tetsuhiro Yoshinami,Junichiro Watanabe,Masahiro Kashiwaba,Ken-ichi Watanabe,Masahiro Kitada,Koichi Sakaguchi,Yuko Tanabe,Tomohiko Aihara,Hirofumi Mukai,Masato Takahashi

CANCER RESEARCH（2023）

引用 0|浏览42
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要